The AHA also called for the CMS to obtain approval from the National Quality Forum as well as pre-rulemaking review from the Measure Application Partnership.
The CMS proposed measures are initiation of osteoclast inhibitors for breast cancer patients with multiple myeloma or cancer metastasized to the bone, overuse of imaging for breast cancers with low risk of metastasizing and avoidable emergency department visits and admissions for outpatient chemotherapy patients.
More Articles on Quality:
Patient Safety Tool: Congestive Heart Failure Discharge Guide
5 Keys to Gain Buy-in to Quality, Safety Measures
Study: Hospitals’ Surgical Quality Differs for Cancer, Non-Cancer Patients
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.